Please join us for a 1-hour introductory session covering the FDA/EMA regulatory strategies for Orphan Drugs & Products. Tim Cote MD MPH, former director of FDA’s Office of Orphan Products Development and currently the CEO of Cote Orphan, LLC. (CIC member), will tell the tale of orphan drugs in America, the major laws which regulate them, and why this is important to biotech. With the wit and drama uncharacteristic of the torpid topic of regulatory affairs, Dr. Cote will tell you how pharmaceutical assets can be augmented in value through regulatory advancement. Inexorably drawing venture capital to your company. Visit here for more info and registration.